A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples
- 1 August 2004
- journal article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 291 (1-2) , 51-62
- https://doi.org/10.1016/j.jim.2004.04.017
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4+ and CD8+ T cell responses in humansProceedings of the National Academy of Sciences, 2004
- Monitoring CD4+ T cell responses against viral and tumor antigens using T cells as novel target APCJournal of Immunological Methods, 2003
- T-cell responses of vaccinated cancer patientsCurrent Opinion in Immunology, 2003
- Rational approaches to human cancer immunotherapyJournal of Leukocyte Biology, 2003
- Cytokine-driven Proliferation and Differentiation of Human Naive, Central Memory, and Effector Memory CD4+ T CellsThe Journal of Experimental Medicine, 2001
- Targeting Antigen in Mature Dendritic Cells for Simultaneous Stimulation of CD4+ and CD8+ T CellsThe Journal of Immunology, 2001
- Evaluation of Cytotoxic T-Lymphocyte Responses in Human and Nonhuman Primate Subjects Infected with Human Immunodeficiency Virus Type 1 or Simian/Human Immunodeficiency VirusJournal of Virology, 2001
- Identification of NY-ESO-1 Peptide Analogues Capable of Improved Stimulation of Tumor-Reactive CTLThe Journal of Immunology, 2000
- Dissecting the Multifactorial Causes of Immunodominance in Class I–Restricted T Cell Responses to VirusesImmunity, 2000
- Modification of Cysteine Residues In Vitro and In Vivo Affects the Immunogenicity and Antigenicity of Major Histocompatibility Complex Class I–restricted Viral DeterminantsThe Journal of Experimental Medicine, 1999